Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Comparison of Amnion Chorion Membrane vs. Dense Polytetrafluoroethylene Membrane in Ridge Preservation Procedures

Phase 2

Completed

Conditions: Alveolar Bone Loss
Pathological Conditions, Anatomical

Interventions: Device: Placing Amnion chorion membrane over grafted site
Device: Placing d-PTFE membrane over grafted site

First Posted Date: 2015-11-11

Last Posted Date: 2016-10-07

Lead Sponsor: Indiana University

Target Recruit Count: 9

Registration Number: NCT02602223

A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL

Phase 2

Terminated

Conditions: Vincristine Induced Neuropathy

Interventions: Drug: Acetylcarnitine
Drug: Placebo

First Posted Date: 2015-11-06

Last Posted Date: 2017-03-03

Lead Sponsor: Indiana University

Target Recruit Count: 8

Registration Number: NCT02598622

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

Completed

Conditions: Heart Failure

First Posted Date: 2015-10-30

Last Posted Date: 2018-06-04

Lead Sponsor: Indiana University

Target Recruit Count: 500

Registration Number: NCT02592135

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
IU Health Methodist Hospital, Indianapolis, Indiana, United States
🇺🇸
Detroit Receiving Hospital, Detroit, Michigan, United States

and more 2 locations

Biorepository for Precision Genomics

Terminated

Conditions: Neoplasms

First Posted Date: 2015-10-27

Last Posted Date: 2020-11-13

Lead Sponsor: Indiana University

Target Recruit Count: 480

Registration Number: NCT02587026

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
IU Health Ball Memorial, Muncie, Indiana, United States

Use of ACTIMMUNE in Patients With ADO2

Phase 2

Completed

Conditions: Autosomal Dominant Osteopetrosis Type 2

Interventions: Drug: ACTIMMUNE

First Posted Date: 2015-10-22

Last Posted Date: 2021-01-08

Lead Sponsor: Indiana University

Target Recruit Count: 12

Registration Number: NCT02584608

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States

miR-200b & miR-21 in Diabetic Wounds

Completed

Conditions: Foot Ulcer
Wound
Diabetes Mellitus
Wound Heal
Ulcer
Diabetic Foot Ulcer

First Posted Date: 2015-10-20

Last Posted Date: 2024-04-25

Lead Sponsor: Indiana University

Target Recruit Count: 98

Registration Number: NCT02581098

Locations: 🇺🇸
IU Health Methodist Hospital, Indianapolis, Indiana, United States
🇺🇸
OSU Hospital East, Columbus, Ohio, United States
🇺🇸
Davis Heart and Lung Research Institute, Columbus, Ohio, United States

and more 1 locations

Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia

Terminated

Conditions: Pancreatic Cancer
Cachexia

First Posted Date: 2015-10-20

Last Posted Date: 2018-02-23

Lead Sponsor: Indiana University

Target Recruit Count: 8

Registration Number: NCT02580422

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Sidney & Lois Eskenazi Hospital, Indianapolis, Indiana, United States

Tocotrienol Against the Progression of End Stage Liver Disease

Phase 2

Recruiting

Conditions: End Stage Liver Disease
NASH - Nonalcoholic Steatohepatitis
NAFLD - Nonalcoholic Fatty Liver Disease

Interventions: Drug: Tocotrienol (TCT)
Other: Placebo

First Posted Date: 2015-10-20

Last Posted Date: 2023-07-20

Lead Sponsor: Indiana University

Target Recruit Count: 70

Registration Number: NCT02581085

Locations: 🇺🇸
IU Health Unviersity Hospital, Indianapolis, Indiana, United States

Wound Healing Endpoint and Recurrence

Phase 1

Suspended

Conditions: Chronic Wound
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Chronic
Burn Wound
Wound

Interventions: Device: Epiceram Skin Barrier Function
Biological: Vaseline Petroleum Jelly

First Posted Date: 2015-10-16

Last Posted Date: 2024-11-12

Lead Sponsor: Sashwati Roy

Target Recruit Count: 100

Registration Number: NCT02577120

Locations: 🇺🇸
University of Pittsburgh / McKeesport Clinic, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Pittsburgh / Mercy Clinic, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Pittsburgh / Passavant, Pittsburgh, Pennsylvania, United States

A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: thiapalmitate tracer
Drug: Saline
Drug: Insulin

First Posted Date: 2015-09-30

Last Posted Date: 2016-08-31

Lead Sponsor: Indiana University

Target Recruit Count: 18

Registration Number: NCT02563834

Locations: 🇺🇸
Indiana University Hospital GCRC, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy